45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,813
Insurances with rates
0
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
68152-103-03
$54,654
IBRITUMOMAB TIUXETAN FOR Y-90 3.2 MG/2ML IV KIT
Gross
$55,769
0003-2328-22
$44,368
IPILIMUMAB 200 MG/40ML IV SOLN
Gross
$45,274
0187-0007-14
$28,092
RIBAVIRIN 6 G IN SOLR
Gross
$28,665
404
$24,735
HC NM MYOCARDIAL IMAGING PET METABOLIC EVALUATION SINGLE STUDY W CT
Gross
$25,240
11994-016-01
$18,851
SAMARIUM SM 153 LEXIDRONAM 1850 MBQ/ML IV SOLN
Gross
$19,235
0024-5824-11
$17,853
CABAZITAXEL 60 MG/1.5ML IV SOLN
Gross
$18,218
50242-245-01
$17,048
PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN
Gross
$17,396
51144-050-01
$15,528
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$15,845
48818-001-02
$14,843
PRALATREXATE 40 MG/2ML IV SOLN
Gross
$15,146
50242-917-01
$14,197
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$14,487
61755-008-01
$13,383
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$13,656
57894-503-01
$12,951
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$13,215
99999-9979-78
$12,835
CABAZITAXEL 10 MG/ML IV SOLN
Gross
$13,097
69344-102-33
$12,219
INDOMETHACIN 50 MG RE SUPP
Gross
$12,468
64764-300-20
$11,466
VEDOLIZUMAB 300 MG IV SOLR
Gross
$11,700
50242-260-01
$11,365
PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN
Gross
$11,597
0003-2327-11
$11,092
IPILIMUMAB 50 MG/10ML IV SOLN
Gross
$11,318
50242-070-01
$11,025
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$11,250
50242-085-27
$10,426
ALTEPLASE 100 MG IV SOLR
Gross
$10,639
50242-918-01
$9,938
ATEZOLIZUMAB 840 MG/14ML IV SOLN
Gross
$10,141
99999-9964-66
$9,915
ALTEPLASE (STROKE) CUSTOM BOLUS (NOT MIXTURE)
Gross
$10,117
50242-120-47
$9,830
TENECTEPLASE 50 MG IV KIT
Gross
$10,031
50242-176-01
$9,830
TENECTEPLASE 50 MG IV KIT
Gross
$10,031
0003-3734-13
$9,730
NIVOLUMAB 240 MG/24ML IV SOLN
Gross
$9,929
0078-0685-15
$9,587
ELTROMBOPAG OLAMINE 25 MG PO TABS
Gross
$9,783
0002-7678-01
$9,192
RAMUCIRUMAB 500 MG/50ML IV SOLN
Gross
$9,380
55513-956-01
$8,585
PANITUMUMAB 400 MG/20ML IV SOLN
Gross
$8,760
50242-145-01
$8,355
PERTUZUMAB 420 MG/14ML IV SOLN
Gross
$8,526
48818-001-01
$8,315
PRALATREXATE 20 MG/ML IV SOLN
Gross
$8,484
66490-691-10
$7,704
PRIMIDONE 250 MG PO TABS
Gross
$7,861
0078-0825-81
$7,702
OCTREOTIDE ACETATE 30 MG IM KIT
Gross
$7,859
70020-1911-1
$7,404
IXABEPILONE 45 MG IV SOLR
Gross
$7,555
0006-3026-02
$7,225
PEMBROLIZUMAB 100 MG/4ML IV SOLN
Gross
$7,372
67919-020-10
$6,683
ALVIMOPAN 12 MG PO CAPS
Gross
$6,819
17156-235-01
$6,079
IOBENGUANE SULFATE I 123 10 MCI/5ML IV SOLN
Gross
$6,203
0009-7224-02
$5,996
LYMPHOCYTE,ANTI-THYMO IMM GLOB 50 MG/ML IV SOLN
Gross
$6,119
0078-0648-81
$5,992
OCTREOTIDE ACETATE 30 MG IM KIT
Gross
$6,114
50633-120-11
$5,893
DIGOXIN IMMUNE FAB 40 MG IV SOLR
Gross
$6,013
52015-080-01
$5,858
FIDAXOMICIN 200 MG PO TABS
Gross
$5,977
71258-022-00
$5,804
PIFLUFOLASTAT F 18 9 MCI IV SOSY
Gross
$5,923
50242-053-06
$5,755
RITUXIMAB 500 MG/50ML IV SOLN
Gross
$5,872
13533-800-40
$5,674
IMMUNE GLOBULIN (HUMAN) 40 GM/400ML IJ SOLN
Gross
$5,790
0019-9050-40
$5,541
INDIUM IN-111 PENTETREOTIDE IV KIT
Gross
$5,654
0006-3026-01
$5,529
PEMBROLIZUMAB 100 MG/4ML IV SOLN
Gross
$5,642
0310-4611-50
$5,261
DURVALUMAB 500 MG/10ML IV SOLN
Gross
$5,368
50242-044-13
$5,213
ALTEPLASE 50 MG IV SOLR
Gross
$5,320
0078-0818-81
$5,143
OCTREOTIDE ACETATE 20 MG IM KIT
Gross
$5,248
0003-3756-14
$4,865
NIVOLUMAB 120 MG/12ML IV SOLN
Gross
$4,964
59676-610-01
$4,519
TRABECTEDIN 1 MG IV SOLR
Gross
$4,612
0944-2700-07
$4,505
GAMMAGARD 30 GM/300ML IJ SOLN
Gross
$4,597
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 68152-103-03 | IBRITUMOMAB TIUXETAN FOR Y-90 3.2 MG/2ML IV KIT | $55,769 | $54,654 | — | — | 0 |
| 0003-2328-22 | IPILIMUMAB 200 MG/40ML IV SOLN | $45,274 | $44,368 | — | — | 0 |
| 0187-0007-14 | RIBAVIRIN 6 G IN SOLR | $28,665 | $28,092 | — | — | 0 |
| 404 | HC NM MYOCARDIAL IMAGING PET METABOLIC EVALUATION SINGLE STUDY W CT | $25,240 | $24,735 | — | — | 0 |
| 11994-016-01 | SAMARIUM SM 153 LEXIDRONAM 1850 MBQ/ML IV SOLN | $19,235 | $18,851 | — | — | 0 |
| 0024-5824-11 | CABAZITAXEL 60 MG/1.5ML IV SOLN | $18,218 | $17,853 | — | — | 0 |
| 50242-245-01 | PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN | $17,396 | $17,048 | — | — | 0 |
| 51144-050-01 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $15,845 | $15,528 | — | — | 0 |
| 48818-001-02 | PRALATREXATE 40 MG/2ML IV SOLN | $15,146 | $14,843 | — | — | 0 |
| 50242-917-01 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $14,487 | $14,197 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $13,656 | $13,383 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $13,215 | $12,951 | — | — | 0 |
| 99999-9979-78 | CABAZITAXEL 10 MG/ML IV SOLN | $13,097 | $12,835 | — | — | 0 |
| 69344-102-33 | INDOMETHACIN 50 MG RE SUPP | $12,468 | $12,219 | — | — | 0 |
| 64764-300-20 | VEDOLIZUMAB 300 MG IV SOLR | $11,700 | $11,466 | — | — | 0 |
| 50242-260-01 | PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN | $11,597 | $11,365 | — | — | 0 |
| 0003-2327-11 | IPILIMUMAB 50 MG/10ML IV SOLN | $11,318 | $11,092 | — | — | 0 |
| 50242-070-01 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $11,250 | $11,025 | — | — | 0 |
| 50242-085-27 | ALTEPLASE 100 MG IV SOLR | $10,639 | $10,426 | — | — | 0 |
| 50242-918-01 | ATEZOLIZUMAB 840 MG/14ML IV SOLN | $10,141 | $9,938 | — | — | 0 |
| 99999-9964-66 | ALTEPLASE (STROKE) CUSTOM BOLUS (NOT MIXTURE) | $10,117 | $9,915 | — | — | 0 |
| 50242-120-47 | TENECTEPLASE 50 MG IV KIT | $10,031 | $9,830 | — | — | 0 |
| 50242-176-01 | TENECTEPLASE 50 MG IV KIT | $10,031 | $9,830 | — | — | 0 |
| 0003-3734-13 | NIVOLUMAB 240 MG/24ML IV SOLN | $9,929 | $9,730 | — | — | 0 |
| 0078-0685-15 | ELTROMBOPAG OLAMINE 25 MG PO TABS | $9,783 | $9,587 | — | — | 0 |
| 0002-7678-01 | RAMUCIRUMAB 500 MG/50ML IV SOLN | $9,380 | $9,192 | — | — | 0 |
| 55513-956-01 | PANITUMUMAB 400 MG/20ML IV SOLN | $8,760 | $8,585 | — | — | 0 |
| 50242-145-01 | PERTUZUMAB 420 MG/14ML IV SOLN | $8,526 | $8,355 | — | — | 0 |
| 48818-001-01 | PRALATREXATE 20 MG/ML IV SOLN | $8,484 | $8,315 | — | — | 0 |
| 66490-691-10 | PRIMIDONE 250 MG PO TABS | $7,861 | $7,704 | — | — | 0 |
| 0078-0825-81 | OCTREOTIDE ACETATE 30 MG IM KIT | $7,859 | $7,702 | — | — | 0 |
| 70020-1911-1 | IXABEPILONE 45 MG IV SOLR | $7,555 | $7,404 | — | — | 0 |
| 0006-3026-02 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $7,372 | $7,225 | — | — | 0 |
| 67919-020-10 | ALVIMOPAN 12 MG PO CAPS | $6,819 | $6,683 | — | — | 0 |
| 17156-235-01 | IOBENGUANE SULFATE I 123 10 MCI/5ML IV SOLN | $6,203 | $6,079 | — | — | 0 |
| 0009-7224-02 | LYMPHOCYTE,ANTI-THYMO IMM GLOB 50 MG/ML IV SOLN | $6,119 | $5,996 | — | — | 0 |
| 0078-0648-81 | OCTREOTIDE ACETATE 30 MG IM KIT | $6,114 | $5,992 | — | — | 0 |
| 50633-120-11 | DIGOXIN IMMUNE FAB 40 MG IV SOLR | $6,013 | $5,893 | — | — | 0 |
| 52015-080-01 | FIDAXOMICIN 200 MG PO TABS | $5,977 | $5,858 | — | — | 0 |
| 71258-022-00 | PIFLUFOLASTAT F 18 9 MCI IV SOSY | $5,923 | $5,804 | — | — | 0 |
| 50242-053-06 | RITUXIMAB 500 MG/50ML IV SOLN | $5,872 | $5,755 | — | — | 0 |
| 13533-800-40 | IMMUNE GLOBULIN (HUMAN) 40 GM/400ML IJ SOLN | $5,790 | $5,674 | — | — | 0 |
| 0019-9050-40 | INDIUM IN-111 PENTETREOTIDE IV KIT | $5,654 | $5,541 | — | — | 0 |
| 0006-3026-01 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $5,642 | $5,529 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 500 MG/10ML IV SOLN | $5,368 | $5,261 | — | — | 0 |
| 50242-044-13 | ALTEPLASE 50 MG IV SOLR | $5,320 | $5,213 | — | — | 0 |
| 0078-0818-81 | OCTREOTIDE ACETATE 20 MG IM KIT | $5,248 | $5,143 | — | — | 0 |
| 0003-3756-14 | NIVOLUMAB 120 MG/12ML IV SOLN | $4,964 | $4,865 | — | — | 0 |
| 59676-610-01 | TRABECTEDIN 1 MG IV SOLR | $4,612 | $4,519 | — | — | 0 |
| 0944-2700-07 | GAMMAGARD 30 GM/300ML IJ SOLN | $4,597 | $4,505 | — | — | 0 |
Showing top 50 of 5,813 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.